Nasdaq

Penumbra (PEN) Enrolls First Patient in Landmark STORM-PE Trial

Penumbra PEN recently announced the enrollment of the first patient in the STORM-PE trial, the first-of-its-kind randomized controlled trial (RCT), which compares computer-assisted vacuum thrombectomy ...
Business Insider

First Patient in STORM-PE RCT Enrolled Evaluating Penumbra's Latest Computer Assisted Vacuum Thrombectomy - Lightning Flash™ - for Treatment of Acute Pulmonary Embolism

ALAMEDA, Calif., Nov. 28, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, announced the first patient enrolled in STORM-PE, a first-of-its ...
AOL

Penumbra Enrolls First Patient for Study on Coronary Vessels

Penumbra, Inc. PEN recently announced enrollment of the first patient into its CHEETAH study. The multi-center U.S. study aims to assess safety and performance of the Indigo System with CAT RX ...
Investing

Penumbra’s thrombectomy treatment shows better outcomes for PE patients

NEW YORK - Penumbra, Inc. (NYSE:PEN) reported Monday that its computer assisted vacuum thrombectomy (CAVT) treatment combined with anticoagulation demonstrated significantly better outcomes for ...
Seeking Alpha

Seven New Data Sets Demonstrate Penumbra's Computer Assisted Vacuum Thrombectomy (CAVT) Technology Is Safe, Fast and Effective, Improves Patient Outcomes, and Delivers ...

ALAMEDA, Calif., April 2, 2025 /PRNewswire/ -- Penumbra, Inc (PEN). (NYSE: PEN), the world's leading thrombectomy company, announced seven significant computer assisted vacuum thrombectomy (CAVT™) ...